Autoimmunity in Dilated Cardiomyopathy and the Major Histocompatibility Complex
Overview
Authors
Affiliations
Autoimmune mechanisms are likely to participate in the pathogenesis of a subgroup of dilated cardiomyopathy. These mechanisms involve the elaboration of autoantibodies against cardiac proteins as well as abnormal lymphocyte regulation. The presence of autoantibodies against beta-adrenoceptors correlates with the human leukocyte antigen (HLA)-DR4/1 phenotypes and specific T-cell receptor haplotypes. In addition, histidine at position 36 of the HLA-DQ beta 1 gene is associated with the presence of clinically manifest dilated cardiomyopathy. Components of the major histocompatibility complex (MHC) may thus serve as markers for the propensity to develop immune-mediated myocardial damage.
Beier P, Reese S, Holler P, Simak J, Tater G, Wess G J Vet Intern Med. 2014; 29(1):141-9.
PMID: 25306963 PMC: 4858054. DOI: 10.1111/jvim.12476.
Antibodies to cardiac receptors.
Boivin-Jahns V, Schlipp A, Hartmann S, Panjwani P, Klingel K, Lohse M Herz. 2012; 37(8):843-8.
PMID: 23183584 DOI: 10.1007/s00059-012-3699-5.
Spontaneous autoimmune myocarditis and cardiomyopathy in HLA-DQ8.NODAbo transgenic mice.
Taneja V, David C J Autoimmun. 2009; 33(3-4):260-9.
PMID: 19811893 PMC: 3574900. DOI: 10.1016/j.jaut.2009.09.005.
Taneja V, Behrens M, Cooper L, Yamada S, Kita H, Redfield M J Mol Cell Cardiol. 2007; 42(6):1054-64.
PMID: 17499268 PMC: 1993806. DOI: 10.1016/j.yjmcc.2007.03.898.
Kuethe F, Braun R, Foerster M, Schlenker Y, Sigusch H, Kroegel C J Clin Immunol. 2006; 26(1):33-9.
PMID: 16418801 DOI: 10.1007/s10875-006-7585-x.